Related Experiment Video
Updated: Nov 6, 2025

A Method for Measuring RNA N6-methyladenosine Modifications in Cells and Tissues
Published on: December 5, 2016
Epigenetic regulation of N6-methyladenosine modifications in obesity
1School of Kinesiology, Shenyang Sport University, Shenyang, China.
Abstract:
Obesity is a serious health issue in the world and is related to a higher risk of suffering metabolic diseases. Understanding the molecular basis of obesity is critical to identify new targets to treat obesity and obesity-associated metabolic diseases. N6-methyladenosine (m6A) modification is the most common form of ribonucleic acid modification, which has attracted increasing interest of researchers in recent years, as it is reported that m6A has vital functions in diseases and everyday life activities. Recent studies showed that m6A modification was decreased in obese adipose tissue, and appeared to play a regulatory role in many obesity-associated biological processes, including adipogenesis, lipid metabolism and insulin resistance. In this review, we discussed the emerging advances in m6A modification in obesity to provide a novel therapeutic strategy for fighting against obesity.
Insights
N6-methyladenosine (m6A) modification, a key RNA process, is reduced in obesity. This review explores m6A
Area of Science:
- Molecular Biology
- Epigenetics
- Metabolic Diseases
Background:
- Obesity is a global health concern linked to metabolic diseases.
- Understanding obesity's molecular underpinnings is crucial for developing treatments.
- N6-methyladenosine (m6A) modification is a prevalent RNA modification with significant biological roles.
Purpose of the Study:
- To review recent advances in understanding m6A modification in obesity.
- To highlight the regulatory role of m6A in obesity-associated processes.
- To propose m6A modification as a therapeutic target for obesity.
Main Methods:
- Literature review of studies on m6A modification and obesity.
- Analysis of m6A's involvement in adipogenesis, lipid metabolism, and insulin resistance.
- Synthesis of current research on m6A's function in adipose tissue.
Main Results:
- m6A modification levels are decreased in obese adipose tissue.
- m6A plays a regulatory role in adipogenesis, lipid metabolism, and insulin resistance.
- Emerging evidence points to m6A's critical involvement in obesity pathogenesis.
Conclusions:
- m6A modification is a significant factor in obesity.
- Targeting m6A pathways may offer novel therapeutic strategies for obesity and related metabolic disorders.
- Further research into m6A's role can lead to effective obesity treatments.
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Histone Modification
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
Histone Modification
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
RNA Editing

